샘플 요청 목록

 카트 문의
시장보고서
상품코드
1788282

세계의 자가조절진통 펌프 시장

Patient-Controlled Analgesic Pumps
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

자가조절진통 펌프 세계 시장은 2030년까지 6억 8,690만 달러에 달할 전망

2024년에 5억 590만 달러로 추정되는 자가조절진통 펌프 세계 시장은 2024년부터 2030년까지 CAGR 5.2%로 성장하여 2030년에는 6억 8,690만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석하고 있는 부문 중 하나인 일렉트로닉스는 CAGR 4.5%를 기록하며 분석 기간 종료시에는 4억 5,560만 달러에 달할 것으로 예측됩니다. 메커니컬 부문의 성장률은 분석 기간 동안 CAGR 6.9%로 추정됩니다.

미국 시장은 1억 3,300만 달러로 추정, 중국은 CAGR 5.1%로 성장 예측

미국의 자가조절진통 펌프 시장은 2024년에 1억 3,300만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 5.1%로 2030년까지 1억 1,040만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 4.5%와 4.6%로 예측됩니다. 유럽에서는 독일이 CAGR 4.3%로 성장할 것으로 예측됩니다.

세계의 자가조절진통 펌프 시장 - 주요 동향과 촉진요인 정리

통증 관리의 새로운 시대? 환자 제어식 진통제 펌프의 채택 증가

통증 관리는 현대 의료에서 중요한 초점이 되고 있으며, 환자 제어형 진통제(PCA) 펌프는 통증 완화 투여 방식에 혁명을 일으키고 있습니다. PCA 펌프는 오피오이드나 국소 마취제 등의 진통제를 정맥, 경막외, 경막하, 피하로 조절하면서 투여함으로써 환자가 스스로 통증을 관리할 수 있도록 하는 장치입니다. PCA 펌프는 수술 후 회복, 암 통증 관리, 완화의료에 널리 사용되며, 간호 인력에 대한 의존도를 낮추면서 맞춤형 진통을 제공합니다. 기존의 통증 관리 방법과 달리 PCA 펌프는 사전 정의된 안전 한도 내에서 주문형 약물 투여가 가능하여 과량 투여 및 부작용의 위험을 최소화합니다. 만성 통증 질환의 유병률 증가, 수술 건수 증가, 통증 관리 프로토콜의 발전은 병원, 외래 수술 센터(ASC), 재택 간호 환경에서 PCA 펌프에 대한 수요를 촉진하고 있습니다. 세계 오피오이드 사태로 인해 처방약 오남용이 우려되는 가운데, PCA 기술은 안전하고 효과적인 통증 관리를 보장하기 위해 용량 제한 기능, 스마트 약물 모니터링, 전자 의료 기록(EHR) 통합을 통합하도록 개선되고 있습니다. 의료 서비스 제공업체가 환자 중심의 접근 방식을 우선시하는 가운데, PCA 펌프는 통증 관리를 강화하고 환자 만족도를 향상시키기 위해 선호되는 솔루션으로 부상하고 있습니다.

AI, 무선 모니터링, 의약품 안전 혁신, 스마트 기술이 PCA 펌프를 어떻게 강화하는가?

스마트 기술의 통합은 PCA 펌프를 더욱 안전하고 효율적이며 현대 의료 시스템에 더 잘 통합되도록 변화시키고 있습니다. 첨단 PCA 펌프는 현재 무선 연결 기능을 갖추고 있어 의료진이 실시간으로 원격 모니터링을 할 수 있어 과량 투여 사고를 방지하고 최적의 통증 관리를 할 수 있습니다. 환자의 반응을 분석하고 오피오이드에 의한 호흡 억제의 초기 징후를 감지하고 그에 따라 투여 파라미터를 조정하기 위해 AI 기반 알고리즘이 PCA 기기에 내장되어 있습니다. 폐쇄 루프 약물전달 시스템 및 바코드를 통한 약물 확인과 같은 약물전달의 혁신은 PCA 펌프의 정확도를 더욱 높이고, 투약 오류를 줄이며, 병원 안전 프로토콜을 준수하도록 보장합니다. 주입 분석 기능을 갖춘 스마트 PCA 펌프는 환자의 사용 패턴을 추적하고 통증 관리 최적화를 위한 예측적 인사이트를 제공할 수 있습니다. 병원 EHR과의 통합을 통해 약물 투여의 자동 문서화가 가능해져 임상 워크플로우의 효율성과 규정 준수를 개선할 수 있습니다. 경피 및 비강 약물전달 시스템을 포함한 비침습적 PCA 기술의 개발은 환자에게 바늘을 사용하지 않는 통증 완화 옵션을 제공하여 인기를 끌고 있습니다. 디지털 헬스 생태계가 진화함에 따라 AI, 데이터 분석, 커넥티드 디바이스의 융합은 PCA 펌프의 전망을 재구성하고 통증 관리를 더욱 안전하고 효과적으로 만들고 있습니다.

PCA 펌프는 어디에 사용되는가? 헬스케어 분야에서의 채택 확대

PCA 펌프는 병원, 외래 수술 센터(ASC), 완화 치료 및 재택치료 환경에서 통증 관리에 필수적인 요소로 자리 잡고 있습니다. 병원에서는 PCA 펌프가 정형외과, 심혈관, 복부 등 대수술 후 급성 통증을 관리하기 위해 수술 후 회복실에서 널리 사용되고 있습니다. 암 치료 센터에서는 PCA 기술을 활용하여 환자가 암과 관련된 극심한 통증을 관리하고, 화학요법 및 완화 치료 중 지속적인 통증 완화를 보장하기 위해 PCA 기술을 활용하고 있습니다. 재택치료 서비스 제공업체는 만성 통증을 앓고 있는 환자가 집에서 진통제를 조절할 수 있도록 휴대용 PCA 펌프를 점점 더 많이 도입하고 있습니다. 외래 수술 센터(ASC)에서는 PCA 장비를 당일 수술 치료 프로토콜에 통합하여 효율적인 진통과 회복 시간 단축을 가능하게 합니다. PCA 펌프는 소아 의료 및 노인 의료 현장에서도 사용되고 있으며, 취약한 환자 집단의 위험을 최소화하도록 설계된 특수 안전 기능을 갖추고 있습니다. 군와 외상 치료 부대는 전장에서 부상 관리에 PCA 기술을 사용하여 원격지에서 부상당한 병사들에게 신속한 통증 완화를 제공하기 위해 PCA 기술의 사용을 모색하고 있습니다. 의료 기관이 첨단 통증 관리 솔루션을 지속적으로 채택함에 따라 다양한 의료 환경에서 PCA 펌프에 대한 수요가 증가하고 있습니다.

자가조절진통 펌프 시장의 성장은 몇 가지 요인에 의해 주도됩니다.

세계 외과 수술 발생률 증가는 PCA 펌프 시장의 성장을 가속하는 주요 요인입니다. 암, 관절염, 신경병성 통증과 같은 만성 통증의 유병률이 증가함에 따라 첨단 통증 관리 솔루션에 대한 수요가 증가하고 있습니다. 환자 중심 치료 모델로의 전환은 의료 서비스 제공업체가 PCA 펌프를 채택하는 원동력이 되고 있으며, 통증 관리에 있어 환자의 자율성을 높여주고 있습니다. AI를 활용한 모니터링, 무선 연결, 자동 약물 투여 제어 등의 기술 발전으로 PCA 펌프는 더욱 안전하고 효율적입니다. 오피오이드 오남용 및 과다복용에 대한 우려가 높아지면서 약물 안전 기능을 강화한 스마트 PCA 펌프가 개발되고 있습니다. 재택치료 및 원격 환자 모니터링의 확대는 휴대용 및 웨어러블 PCA 기기에 새로운 기회를 제공합니다. 안전한 통증 관리 관행과 오피오이드 스튜어드십 프로그램을 촉진하는 규제 의무화는 병원과 의료 기관에서 PCA 펌프의 채택을 촉진하고 있습니다. 디지털 의료 인프라에 대한 투자 증가는 PCA 펌프와 병원의 전자 의료 기록(EHR) 및 임상의사결정지원시스템과의 원활한 통합을 촉진하고 있습니다. 의료기기 제조업체와 제약회사의 전략적 제휴는 통증 완화 기술의 혁신을 촉진하고 있습니다. 헬스케어 시스템이 정밀의료와 데이터 기반 통증 관리 전략으로 진화하는 가운데, 환자 제어식 진통제 펌프 시장은 지속적인 성장세를 보이며 통증 치료의 미래를 변화시킬 것입니다.

부문

유형(전자식, 기계식), 용도(당뇨병, 종양학, 소화기병, 혈액학, 기타), 최종 용도(병원, 전문 클리닉, 외래 수술 센터, 재택의료 현장)

조사 대상 기업 사례

  • Abbott Laboratories
  • Ace Medical
  • Arcomed AG
  • Avanos Medical, Inc.
  • Avante Health Solutions
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company(BD)
  • Changzhou Medical Bioengineering Co., Ltd.
  • Fresenius SE & Co. KGaA
  • Henan Tuoren Medical Device Co., Ltd.
  • ICU Medical, Inc.
  • Medtronic plc
  • Micrel Medical Devices SA
  • Pfizer Inc.(Hospira)
  • Q-Core Medical Ltd.
  • SCW Medicath Ltd.
  • Smiths Medical(ICU Medical)
  • Terumo Corporation
  • Zhejiang Runqiang Medical Instruments

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSM 25.08.21

Global Patient-Controlled Analgesic Pumps Market to Reach US$686.9 Million by 2030

The global market for Patient-Controlled Analgesic Pumps estimated at US$505.9 Million in the year 2024, is expected to reach US$686.9 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Electronic, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$455.6 Million by the end of the analysis period. Growth in the Mechanical segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$133.0 Million While China is Forecast to Grow at 5.1% CAGR

The Patient-Controlled Analgesic Pumps market in the U.S. is estimated at US$133.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$110.4 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Patient-Controlled Analgesic Pumps Market - Key Trends & Drivers Summarized

Is Pain Management Entering a New Era? The Growing Adoption of Patient-Controlled Analgesic Pumps

Pain management has become a critical focus in modern healthcare, with patient-controlled analgesic (PCA) pumps revolutionizing the way pain relief is administered. These devices empower patients to manage their own pain by delivering controlled doses of analgesic medication, typically opioids or local anesthetics, through intravenous (IV), epidural, or subcutaneous routes. PCA pumps are widely used in post-surgical recovery, cancer pain management, and palliative care, offering personalized pain relief while reducing dependency on nursing staff. Unlike conventional pain management methods, PCA pumps allow for on-demand drug administration within predefined safety limits, minimizing the risk of overmedication and adverse effects. The increasing prevalence of chronic pain conditions, rising surgical volumes, and advancements in pain management protocols are driving the demand for PCA pumps across hospitals, ambulatory surgical centers, and home care settings. With the global opioid crisis raising concerns over prescription drug misuse, PCA technology is being refined to incorporate dose-limiting features, smart drug monitoring, and electronic health record (EHR) integration to ensure safe and effective pain management. As healthcare providers prioritize patient-centered approaches, PCA pumps are emerging as a preferred solution for enhancing pain control and improving patient satisfaction.

How Are Smart Technologies Enhancing PCA Pumps? AI, Wireless Monitoring & Drug Safety Innovations

The integration of smart technologies is transforming PCA pumps, making them safer, more efficient, and better integrated into modern healthcare systems. Advanced PCA pumps now feature wireless connectivity, allowing real-time remote monitoring by healthcare providers to prevent overdose incidents and ensure optimal pain management. AI-powered algorithms are being incorporated into PCA devices to analyze patient responses, detect early signs of opioid-induced respiratory depression, and adjust dosage parameters accordingly. Drug safety innovations such as closed-loop drug delivery systems and barcode medication verification are further enhancing the accuracy of PCA pumps, reducing medication errors, and ensuring compliance with hospital safety protocols. Smart PCA pumps equipped with infusion analytics can track patient usage patterns and provide predictive insights for pain management optimization. Integration with hospital EHRs enables automated documentation of drug administration, improving clinical workflow efficiency and regulatory compliance. The development of non-invasive PCA technologies, including transdermal and intranasal drug delivery systems, is also gaining traction, offering patients needle-free pain relief options. As digital health ecosystems evolve, the convergence of AI, data analytics, and connected devices is reshaping the PCA pump landscape, making pain management safer and more effective.

Where Are PCA Pumps Being Used? Expanding Adoption Across Healthcare Settings

PCA pumps are becoming an essential component of pain management in hospitals, outpatient surgical centers, palliative care, and home healthcare settings. In hospitals, PCA pumps are widely used in post-operative recovery units to manage acute pain following major surgeries such as orthopedic, cardiovascular, and abdominal procedures. Cancer treatment centers are leveraging PCA technology to help patients manage severe cancer-related pain, ensuring continuous relief during chemotherapy and palliative care. Home healthcare providers are increasingly deploying portable PCA pumps to allow patients with chronic pain conditions to receive controlled analgesia in a home setting, reducing hospital visits and improving quality of life. Ambulatory surgical centers are integrating PCA devices into same-day surgical care protocols, enabling efficient pain relief with faster recovery times. Pediatric and geriatric care settings are also adopting PCA pumps, with specialized safety features designed to minimize risks in vulnerable patient populations. Military and trauma care units are exploring the use of PCA technology for battlefield injury management, providing rapid pain relief to injured soldiers in remote locations. As healthcare facilities continue to embrace advanced pain management solutions, the demand for PCA pumps is growing across diverse medical environments.

The Growth in the Patient-Controlled Analgesic Pumps Market Is Driven by Several Factors…

The rising incidence of surgical procedures worldwide is a key driver fueling the growth of the PCA pump market. The increasing prevalence of chronic pain conditions such as cancer, arthritis, and neuropathic pain is boosting demand for advanced pain management solutions. The shift toward patient-centric care models is driving healthcare providers to adopt PCA pumps, enhancing patient autonomy in pain management. Technological advancements, including AI-powered monitoring, wireless connectivity, and automated drug dose control, are making PCA pumps safer and more efficient. The rising concerns over opioid misuse and overdose are leading to the development of smart PCA pumps with enhanced drug safety features. The expansion of home healthcare and remote patient monitoring is creating new opportunities for portable and wearable PCA devices. Regulatory mandates promoting safe pain management practices and opioid stewardship programs are encouraging the adoption of PCA pumps in hospitals and healthcare institutions. The increasing investment in digital health infrastructure is facilitating seamless integration of PCA pumps with hospital electronic health records (EHRs) and clinical decision support systems. Strategic collaborations between medical device manufacturers and pharmaceutical companies are driving innovations in pain relief technologies. As healthcare systems continue to evolve toward precision medicine and data-driven pain management strategies, the patient-controlled analgesic pump market is set for sustained growth, transforming the future of pain therapy.

SCOPE OF STUDY:

The report analyzes the Patient-Controlled Analgesic Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Electronic, Mechanical); Application (Diabetes, Oncology, Gastroenterology, Hematology, Others); End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Home Care Settings)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • Ace Medical
  • Arcomed AG
  • Avanos Medical, Inc.
  • Avante Health Solutions
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Changzhou Medical Bioengineering Co., Ltd.
  • Fresenius SE & Co. KGaA
  • Henan Tuoren Medical Device Co., Ltd.
  • ICU Medical, Inc.
  • Medtronic plc
  • Micrel Medical Devices SA
  • Pfizer Inc. (Hospira)
  • Q-Core Medical Ltd.
  • SCW Medicath Ltd.
  • Smiths Medical (ICU Medical)
  • Terumo Corporation
  • Zhejiang Runqiang Medical Instruments

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Patient-Controlled Analgesic Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Post-Surgical Pain Management Protocols Accelerates Demand for Patient-Controlled Analgesic Pumps
    • Focus on Personalized Pain Therapy Drives Adoption of PCA Devices
    • Growth in Ambulatory Surgical Centers Expands Use of Portable Analgesic Pumps
    • Integration with Digital Health Records Strengthens Monitoring and Control Capabilities
    • Rising Opioid Safety Concerns Throw the Spotlight on Controlled Drug Delivery Solutions
    • Demand for Non-Invasive Pain Management Spurs Innovation in Pump-Based Therapies
    • Increasing Patient Preference for Self-Managed Pain Relief Drives PCA Device Utilization
    • AI-Enhanced Dosage Monitoring Improves Accuracy and Minimizes Overdose Risk
    • Regulatory Scrutiny on Drug Delivery Devices Spurs Development of Tamper-Resistant Pumps
    • Hospital Efforts to Reduce Nursing Workload Strengthen Use of Automated PCA Systems
    • Expansion of Home Recovery Programs Supports Demand for Compact, User-Friendly Pumps
    • Growth in Pediatric and Geriatric Surgery Volumes Creates Niche PCA Product Demand
    • Clinical Trials Supporting Efficacy Drive Confidence and Market Acceptance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Patient-Controlled Analgesic Pumps Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Electronic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Electronic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Mechanical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Mechanical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • JAPAN
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • CHINA
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • EUROPE
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • FRANCE
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • GERMANY
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • UNITED KINGDOM
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Patient-Controlled Analgesic Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Type - Electronic and Mechanical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Type - Percentage Breakdown of Value Sales for Electronic and Mechanical for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by End-Use - Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Home Care Settings, Hospitals and Specialty Clinics for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Patient-Controlled Analgesic Pumps by Application - Diabetes, Oncology, Gastroenterology, Hematology and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Patient-Controlled Analgesic Pumps by Application - Percentage Breakdown of Value Sales for Diabetes, Oncology, Gastroenterology, Hematology and Others for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제